Maxim Pavlenko

555 total citations
12 papers, 430 citations indexed

About

Maxim Pavlenko is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Maxim Pavlenko has authored 12 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Maxim Pavlenko's work include Immunotherapy and Immune Responses (9 papers), vaccines and immunoinformatics approaches (3 papers) and RNA Interference and Gene Delivery (3 papers). Maxim Pavlenko is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), vaccines and immunoinformatics approaches (3 papers) and RNA Interference and Gene Delivery (3 papers). Maxim Pavlenko collaborates with scholars based in Sweden, United States and Germany. Maxim Pavlenko's co-authors include Pavel Pisa, Anna‐Karin Roos, Christoph Leder, Sonia Carreño-Moreno, Andreas Lundqvist, Lars Egevad, Alan King, Andreas Palmborg, Rolf Kiessling and Annika Roos and has published in prestigious journals such as British Journal of Cancer, Vaccine and Molecular Therapy.

In The Last Decade

Maxim Pavlenko

12 papers receiving 413 citations

Peers

Maxim Pavlenko
Cindy Zuleger United States
Robert Weth Germany
Murrium Ahmad United Kingdom
Karen O. Allen United States
M Berger Austria
Chris Twitty United States
Johanna K. Hansen United States
Maxim Pavlenko
Citations per year, relative to Maxim Pavlenko Maxim Pavlenko (= 1×) peers Kristian Hallermalm

Countries citing papers authored by Maxim Pavlenko

Since Specialization
Citations

This map shows the geographic impact of Maxim Pavlenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Pavlenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Pavlenko more than expected).

Fields of papers citing papers by Maxim Pavlenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim Pavlenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Pavlenko. The network helps show where Maxim Pavlenko may publish in the future.

Co-authorship network of co-authors of Maxim Pavlenko

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim Pavlenko. A scholar is included among the top collaborators of Maxim Pavlenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim Pavlenko. Maxim Pavlenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Puzachenko, A. Yu., et al.. (2014). Karyotype, genetic and morphological variability in North China zokor, Myospalax psilurus (Rodentia, Spalacidae, Myospalacinae). Russian Journal of Theriology. 13(1). 27–46. 10 indexed citations
2.
Roos, Anna‐Karin, Maxim Pavlenko, Christoph Leder, et al.. (2009). A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols. Vaccine. 27(10). 1557–1565. 4 indexed citations
3.
Pavlenko, Maxim, Christoph Leder, Sonia Carreño-Moreno, Victor Levitsky, & Pavel Pisa. (2007). Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice. Vaccine. 25(34). 6341–6347. 16 indexed citations
4.
Lundqvist, Andreas, Andreas Palmborg, Maxim Pavlenko, Jelena Levitskaya, & Pavel Pisa. (2005). Mature Dendritic Cells Induce Tumor-Specific Type 1 Regulatory T Cells. Journal of Immunotherapy. 28(3). 229–235. 19 indexed citations
5.
Pavlenko, Maxim, Christoph Leder, Anna‐Karin Roos, Victor Levitsky, & Pavel Pisa. (2005). Identification of an immunodominant H‐2Db‐restricted CTL epitope of human PSA. The Prostate. 64(1). 50–59. 20 indexed citations
6.
Roos, Anna‐Karin, Sonia Carreño-Moreno, Christoph Leder, et al.. (2005). Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Molecular Therapy. 13(2). 320–327. 102 indexed citations
7.
Pavlenko, Maxim, Christoph Leder, & Pavel Pisa. (2005). Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens. Expert Review of Vaccines. 4(3). 315–327. 9 indexed citations
8.
Pavlenko, Maxim, et al.. (2004). Comparison of PSA-specific CD8+ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteins. Cancer Immunology Immunotherapy. 53(12). 1085–1092. 14 indexed citations
9.
Roos, Anna‐Karin, Maxim Pavlenko, Jehad Charo, Lars Egevad, & Pavel Pisa. (2004). Induction of PSA‐specific CTLs and anti‐tumor immunity by a genetic prostate cancer vaccine. The Prostate. 62(3). 217–223. 42 indexed citations
10.
Pavlenko, Maxim, Annika Roos, Andreas Lundqvist, et al.. (2004). A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. British Journal of Cancer. 91(4). 688–694. 148 indexed citations
11.
Alimov, Andrei, Birgitta Sundelin, Ulf S.R. Bergerheim, et al.. (2004). Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.. International Journal of Oncology. 25(4). 955–1015. 9 indexed citations
12.
Lundqvist, Andreas, Gabriele Noffz, Maxim Pavlenko, et al.. (2002). Nonviral and Viral Gene Transfer Into Different Subsets of Human Dendritic Cells Yield Comparable Efficiency of Transfection. Journal of Immunotherapy. 25(6). 445–454. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026